Harnessing Immunity to Fight Cancer and Viruses
NK cell therapy is a treatment that leverages the power of “NK cells,” immune cells that our bodies are naturally equipped with.
“NK cells” is short for natural killer cells. They are a type of white blood cell and a mainstay of innate (inborn) immunity. They constantly patrol the blood and organs, monitoring for abnormal cells that could threaten the body.
Specifically, NK cells have receptors—like antennas—on their surface to detect abnormalities, and when they identify “suspicious cells” such as virus-infected cells or cancer cells, they immediately initiate an attack.
As their name suggests, these “natural killers” eliminate abnormal cells with high responsiveness.
In NK cell therapy, NK cells are first collected from the body, expanded and activated outside the body, and then returned to strengthen the ability to fight disease.
Rather than relying on complex medications, this therapy boosts the power of your own immune system and is attracting attention as a form of cancer immunotherapy.
The Role of Immunity and the Importance of NK Cells
Our bodies rely on the immune system to protect us from threats such as bacteria, viruses, and cancer cells. Broadly, immunity is divided into “innate immunity,” which we are born with, and “adaptive immunity,” which we acquire over time.
NK cells are representative of innate immunity. Using inborn capabilities, they quickly detect and eliminate abnormalities. For example, cells infected by cold viruses and the small cancerous cells that arise daily are, in many cases, promptly handled by NK cells, helping maintain health.
When NK cell function weakens, we become more susceptible to viral infections and may permit cancer cells to proliferate. NK cells therefore play a critical role in maintaining health.
How NK Cell Therapy Works
NK cell therapy proactively harnesses the strength of NK cells.
In practice, NK cells from the patient or from a donor are collected, then expanded and activated under specialized conditions outside the body before being returned to the patient.
Using a process called culturing (培養), NK cells are multiplied many times over and stimulated with substances such as interleukin-2 (IL-2) and interferon-gamma (IFN-γ) to shift them into a more active “combat mode.”
Reinfusing these NK cells by IV allows them to fight cancer cells and virus-infected cells more powerfully inside the patient.
In other words, NK cell therapy “reinforces and powers up the internal patrol,” boosting the body’s ability to combat disease. (※ “Culturing” refers to increasing cells in test tubes or dedicated equipment.)
Mechanisms of NK Cells
How NK Cells Work in the Body
NK cells act as vigilant sentinels throughout the body. To distinguish normal from abnormal cells, they inspect the molecular signals presented on cell surfaces.
Healthy cells display “I am normal” signals; virus-infected or cancer cells, however, often show disturbed or missing signals.
NK cells sense these irregularities via their receptors and, upon judging “this cell may be dangerous,” take action immediately.
NK cells respond extremely quickly and are pre-programmed from birth, so they can detect and address threats without prior learning.
As a rapid-response force, they act early—during initial infection or when cancer is just beginning.
Attack Mechanisms Against Cancer and Abnormal Cells
When NK cells identify abnormal cells, they attack them directly. There are two major mechanisms:
First, NK cells contact the abnormal cell and release a substance called perforin. Perforin punches holes in the target cell’s membrane, damaging it.
Second, after forming these pores, NK cells deliver enzymes called granzymes into the target. Granzymes enter the cell and trigger its internal “self-destruct switch,” leading to cell death.
Through these methods, NK cells destroy virus-infected and cancer cells from within and clear them safely. Because NK cell attacks do not require special prior instructions, they can reduce threats faster than adaptive immunity (T cells and B cells), which engages after infection has progressed.
Benefits of NK Cell Therapy (Strengthening Innate Immunity, Cancer Control, etc.)
NK cell therapy offers several advantages. First, it strengthens innate immunity. By enhancing the patient’s own immune capacity, overall defenses rise, potentially helping to prevent recurrence and other infections.
Second, cancer control can be expected. Activated NK cells not only directly attack and reduce cancer cells, but by damaging tumor cells they may also produce synergy when combined with other treatments (e.g., chemotherapy or radiation).
NK cell therapy is also considered relatively safe (as detailed below, severe adverse events are uncommon). Moreover, because NK cells can respond to a variety of cancers and viruses, they may eliminate a broad range of abnormal cells beyond single, narrowly defined targets.
In this way, NK cell therapy is a novel treatment option that bolsters the body’s inborn strength to fight disease.
Applications of NK Cell Therapy
Diseases and Conditions Where NK Cell Therapy Is Expected (Cancer, Immune Suppression, Viral Infections, etc.)
NK cell therapy has potential across many fields; most notably, in cancer treatment.
For solid tumors (e.g., lung, liver, breast) and hematologic cancers (leukemia, lymphoma), research is underway to evaluate the effectiveness of NK cell therapy. Clinical studies in cancer patients have begun to report outcomes such as tumor shrinkage and slowed progression.
NK cell therapy may also help where immunity is compromised—for example, in older adults, people with severe illnesses, or patients whose immune cells are depleted after bone marrow transplantation or chemotherapy. Supplementing NK cells may aid infection prevention and support recovery.
Furthermore, applications to viral infections are being investigated. Because NK cells can attack virus-infected cells, they are being studied for chronic viral infections (e.g., hepatitis B/C) and as a strategy to prevent severe disease from emerging viruses.
Lastly, NK cell therapy is drawing interest in areas such as anti-aging and prevention of lifestyle-related diseases. NK cell function is known to decline with age; by keeping immune surveillance active, researchers are exploring whether NK therapy could curb age-related diseases and extend healthy lifespan.
Thus, NK cell therapy holds promise for needs ranging from cancer treatment to immune care and preventive medicine.
Expected Benefits (Cancer Immunotherapy, Viral Infection Control, Anti-Aging)
Specific potential benefits of NK cell therapy by area include:
-
As Cancer Immunotherapy:
Activated NK cells patrol the body and directly attack cancer cells, potentially shrinking tumors and suppressing growth. By injuring tumor cells, they may also enhance the effectiveness of other treatments (chemotherapy, radiation). Reduced risk of recurrence may also be possible.
-
For Viral Infection Control:
Because NK cells can rapidly eliminate infected cells, they may help lower viral load in chronic infections and prevent severe disease when infections occur. In people with weakened immunity, supplementing NK cells could also help prevent secondary infections such as influenza or pneumonia.
-
Anti-Aging & Health Maintenance:
By activating innate immunity, NK therapy may enhance day-to-day control over cellular abnormalities (early cancerous changes, accumulation of senescent cells). As a result, it could help prevent age-related diseases and improve overall health. Some patients report everyday benefits such as “catching fewer colds” or “feeling less fatigued.”
In short, NK cell therapy offers not only direct treatment benefits but also potential preventive and quality-of-life improvements.
Note, however, that responses vary among individuals, and the same effects are not guaranteed for every patient.
As ongoing clinical research accumulates, the effectiveness and appropriate indications will become clearer.
How NK Cell Therapy Is Performed
From Collection to Infusion (Blood Draw → Culture → IV)
NK cell therapy generally proceeds in three steps: “collect NK cells” → “expand and activate them” → “return them to the body.” A typical flow is as follows:
-
NK Cell Collection (Blood Draw):
Blood is drawn from a vein in the patient’s arm. The amount varies by treatment, but usually several tens of milliliters (one to a few large syringes—less than a blood donation). NK cells contained in this blood will be isolated later. In autologous therapy, the patient’s own blood is used; in allogeneic therapy, NK cells may be collected from a donor’s blood or cord blood.
-
NK Cell Culture and Activation:
The collected blood is sent to a specialized cell culture facility. There, NK cells are separated from other cells and cultured (expanded). Over about 1–2 weeks, NK cells are increased to the order of billions. At the same time, stimulants such as IL-2 and other factors are added to activate NK cells and boost their tumor-killing readiness. Throughout culture, sterile conditions and strict controls are maintained to prevent contamination or unwanted changes.
-
NK Cell Administration (IV Infusion):
Once expanded and activated sufficiently, NK cells are placed into an IV bag and returned to the clinic. They are administered by infusion or injection. For an IV drip, NK cells are slowly infused through a vein—similar to a transfusion or medication drip. The infusion typically takes several tens of minutes to about an hour and is not particularly painful. In some cases, local injections may be used for specific sites (e.g., near a tumor). After administration, patients rest briefly while their condition is monitored.
That completes one treatment cycle. Because culture takes about 1–2 weeks, scheduling is coordinated in advance.
Practically speaking, a blood draw day and an infusion day are set. Patients live as usual in between and return for infusion once culture is complete. Hospitalization is typically unnecessary; both the blood draw and infusion are often done on an outpatient basis.
Administration Options (IV, Local Injection, Single Session vs. Ongoing Therapy)
The route and frequency of NK cell administration are tailored to the patient’s condition and treatment goals. Main options include:
Route: Systemic administration by IV infusion is most common. By circulating activated NK cells throughout the body, this approach can target cancer or virus-infected cells wherever they may be.
When concentrated effect at a specific site is desired, local injections may be considered—for example, catheter infusion into hepatic vessels for liver cancer, or injections around a skin tumor.
However, local injections are available only at certain facilities and may not affect lesions elsewhere in the body, so decisions are made case-by-case.
Frequency & Schedule: Some regimens use a single administration, while many employ repeated courses. Because infused NK cells act for a time but gradually decline, periodic additional infusions are often preferred to sustain or enhance effects.
For example, an infusion every two weeks for several months—totaling 5–6 sessions—may be used as one course. Depending on the patient, courses may be extended or intervals adjusted.
Conversely, if the purpose is recurrence prevention or immune maintenance, additional infusions may be given as needed at wider intervals while monitoring the patient.
Route and frequency are determined by balancing efficacy and burden. Physicians plan the optimal regimen in consultation with patients; feel free to ask questions about “how many times” and “how far apart,” which vary by individual and are explained during treatment planning.
Treatment Duration and Scheduling (Frequency and Number of Sessions Suited to the Patient)
While duration varies by patient, a common example is:
One course of six infusions over about three months. After the initial blood draw and ~2-week culture, the first infusion is performed.
Then, every two weeks, the draw → culture → infusion cycle is repeated for a total of six sessions (about 12 weeks). After the sixth infusion, efficacy is evaluated to decide whether to stop, pause and monitor, or begin another course.
Some plans are shorter; others involve long-term maintenance at wider intervals. Cancer treatment often uses more concentrated, multiple sessions, whereas immune maintenance or anti-aging purposes may continue at a pace of once every few months to half-year.
The key is to adjust flexibly based on condition and response. If effects are insufficient, switching to other therapies may be considered; if doing well, intervals may be extended and care shifted to observation.
Discuss scheduling thoroughly in advance, accounting for lifestyle. If you are concerned about visit frequency or duration, ask whether adjustments are possible.
Although NK cell therapy is relatively light in patient burden, it still requires regular visits, so setting a sustainable pace is crucial to success.
Comparison with Other Immunotherapies (CAR-T, PD-1 Inhibitors, etc.)
When discussing the safety of NK cell therapy, it is often compared with other immunotherapies such as CAR-T therapy and immune checkpoint inhibitors (e.g., PD-1 inhibitors). While all are prominent modern treatments, their side-effect profiles differ.
Compared with CAR-T: CAR-T uses genetically engineered T cells and can be extremely potent against cancer. However, that power can bring risks such as cytokine release syndrome (dangerous immune overactivation causing high fever and low blood pressure) and neurotoxicity (neurologic symptoms like altered consciousness or seizures). Intensive care may be required in some cases.
By contrast, with NK cell therapy, severe adverse events of this nature have been reported far less frequently. NK cells typically do not expand uncontrollably or persist excessively, making runaway reactions less likely.
Thus, NK therapy is said to have a wider safety margin. That said, whereas CAR-T may produce large effects with a single administration, NK cell therapy often requires repeated sessions.
Compared with Checkpoint Inhibitors: PD-1 inhibitors (e.g., nivolumab [Opdivo] and pembrolizumab [Keytruda]) enhance T-cell anticancer activity by releasing immune “brakes.”
They can be highly effective, but removing the brakes may cause immune-related adverse events in which the immune system attacks normal organs—leading to pneumonitis, colitis, hepatitis, skin rashes, endocrine abnormalities, and more.
Because severe cases can be life-threatening, careful monitoring and, when necessary, immunosuppressive treatment are essential with checkpoint inhibitors.
NK cell therapy introduces cells from outside the body, but because NK cells are an innate component of the immune system, they rarely attack normal tissues as in autoimmunity. Put simply, NK cells primarily act on abnormal targets and generally spare healthy cells, limiting the range of side effects.
However, as noted earlier, when using allogeneic NK cells, attention to potential allergic reactions and related issues is still necessary.
In summary, compared with other cutting-edge immunotherapies, NK cell therapy tends to have a lower side-effect risk. Each therapy has pros and cons—and in some cases other treatments are more appropriate—but from a safety standpoint NK therapy is a comparatively gentle option for many patients.
NK cell therapy is an advanced treatment that maximizes the body’s innate immune power. By activating and augmenting NK cells that directly attack cancer and virus-infected cells, it strengthens the ability to fight disease.
Notably, it generally involves fewer side effects and is less physically taxing. Used in combination with conventional immunotherapies or cancer treatments, additional synergy may be achieved. NK therapy is also being explored for immune maintenance and anti-aging, enabling ongoing care as part of a healthy-lifestyle strategy.
At our clinic, we provide personalized treatment plans tailored to each patient’s condition. Through thorough pre-treatment consultations, we propose optimal approaches and carry out procedures with safety as the highest priority.